Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC | MicrobiomeTrials← Back to trialsNCT06510660
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-04-11Est. Completion: 2027-12
Enrollment target: 48 participants Locations- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Other microbiome trials you might be interested in
Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
The purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, and efficacy of tislelizumab administ…
Yokohama, JapanEst. completion Feb 28, 2028
Locally Advanced or Metastatic Solid Tumors
This is an early development study of ASP388B in people with solid tumors. In this study, ASP388B will be given to peopl…
Lake Success, United StatesEst. completion Feb 28, 2030